OFI Invest Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.4M Buy
45,592
+44,785
+5,550% +$16.6M 0.15% 119
2026
Q1
$205K Buy
807
+161
+25% +$52.9K ﹤0.01% 335
2025
Q4
$193K Buy
646
+312
+93% +$105K ﹤0.01% 324
2025
Q3
$91.8K Buy
334
+99
+42% +$30.8K ﹤0.01% 285
2025
Q2
$77.9K Buy
235
+42
+22% +$16.9K ﹤0.01% 298
2025
Q1
$77.7K Buy
193
+111
+135% +$44.6K ﹤0.01% 273
2024
Q4
$29.2K Buy
+82
New +$34.3K ﹤0.01% 362
2024
Q2
$33.4K Buy
66
+3
+5% +$1.59K ﹤0.01% 304
2024
Q1
$30.2K Buy
63
+3
+5% +$1.49K ﹤0.01% 243
2023
Q4
$25.6K Hold
60
﹤0.01% 253
2023
Q3
$24.7K Buy
+60
New +$27.2K ﹤0.01% 230

Other funds holding ELV

OFI Invest Asset Management's ELV Position: Q2 2026 in Review

OFI Invest Asset Management increased its Elevance Health (ELV) stake by 5,550% in Q2 2026, buying an estimated $16.6M and bringing the position to 45,592 shares worth $15.4M. The position accounts for 0.15% of the portfolio, ranked #119.

OFI Invest Asset Management first reported a position in ELV in Q3 2023 and has held it in 11 quarters since. 977 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • OFI Invest Asset Management held 45,592 shares of Elevance Health worth $15.4M as of Q2 2026.
  • OFI Invest Asset Management bought 44,785 Elevance Health shares in Q2 2026, an estimated $16.6M.
  • Elevance Health made up 0.15% of OFI Invest Asset Management's portfolio in Q2 2026, its #119 holding.
  • OFI Invest Asset Management first reported a position in Elevance Health in Q3 2023 and has held it in 11 quarters since.
  • 977 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.